
Hong Kong SAR, China - Medicaments Containing Insulin But not Antibiotics - Market Analysis, Forecast, Size, Trends and Insights
Hong Kong SAR, China: Medicaments Containing Insulin Market 2023
Medicaments Containing Insulin Market Size in Hong Kong SAR, China
The Hong Kong medicaments containing insulin market dropped notably to $X in 2021, with a decrease of -47.4% against the previous year. Overall, consumption continues to indicate a relatively flat trend pattern. As a result, consumption reached the peak level of $X, and then fell dramatically in the following year.
Medicaments Containing Insulin Production in Hong Kong SAR, China
In value terms, medicaments containing insulin production stood at $X in 2021 estimated in export price. Over the period under review, production recorded a prominent increase. The pace of growth appeared the most rapid in 2019 when the production volume increased by 59% against the previous year. As a result, production attained the peak level of $X. From 2020 to 2021, production growth failed to regain momentum.
Medicaments Containing Insulin Exports
Exports from Hong Kong SAR, China
In 2021, overseas shipments of medicaments containing insulin but not antibiotics decreased by 0% to X tons, falling for the second year in a row after six years of growth. Over the period under review, exports posted a significant expansion. The most prominent rate of growth was recorded in 2019 with an increase of 413% against the previous year. As a result, the exports attained the peak of X tons. From 2020 to 2021, the growth of the exports remained at a somewhat lower figure.
In value terms, medicaments containing insulin exports amounted to $X in 2021. In general, exports continue to indicate a significant expansion. The most prominent rate of growth was recorded in 2019 with an increase of 947%. As a result, the exports reached the peak of $X. From 2020 to 2021, the growth of the exports failed to regain momentum.
Exports by Country
Denmark (X kg) was the main destination for medicaments containing insulin exports from Hong Kong SAR, with a approx. 50% share of total exports.
From 2012 to 2021, the average annual rate of growth in terms of volume to Denmark was relatively modest.
From 2012 to 2021, the average annual rate of growth in terms of value to Denmark was relatively modest.
Export Prices by Country
The average medicaments containing insulin export price stood at $X per ton in 2021, therefore, remained relatively stable against the previous year. Over the period under review, the export price saw prominent growth. The pace of growth appeared the most rapid in 2019 when the average export price increased by 104%. The export price peaked in 2021 and is expected to retain growth in years to come.
As there is only one major export destination, the average price level is determined by prices for Denmark.
From 2012 to 2021, the rate of growth in terms of prices for Denmark amounted to 0.0% per year.
Medicaments Containing Insulin Imports
Imports into Hong Kong SAR, China
Medicaments containing insulin imports into Hong Kong SAR declined to X kg in 2021, shrinking by -11.1% against the previous year. Overall, imports faced a drastic downturn. The pace of growth appeared the most rapid in 2015 with an increase of 884% against the previous year. As a result, imports reached the peak of X kg. From 2016 to 2021, the growth of imports failed to regain momentum.
In value terms, medicaments containing insulin imports soared to $X in 2021. In general, imports saw a perceptible decline. The pace of growth appeared the most rapid in 2015 when imports increased by 454% against the previous year. As a result, imports reached the peak of $X. From 2016 to 2021, the growth of imports remained at a lower figure.
Imports by Country
In 2021, the United States (X kg) was the main medicaments containing insulin supplier to Hong Kong SAR, with a approx. 100% share of total imports.
From 2012 to 2021, the average annual rate of growth in terms of volume from the United States amounted to -10.6%.
In value terms, the United States ($X) constituted the largest supplier of medicaments containing insulin but not antibiotics to Hong Kong SAR.
From 2012 to 2021, the average annual rate of growth in terms of value from the United States was relatively modest.
Import Prices by Country
In 2021, the average medicaments containing insulin import price amounted to $X per ton, increasing by 43% against the previous year. Overall, the import price continues to indicate resilient growth. The most prominent rate of growth was recorded in 2019 an increase of 153%. Over the period under review, average import prices attained the maximum in 2021 and is likely to see gradual growth in the near future.
As there is only one major supplying country, the average price level is determined by prices for the United States.
From 2012 to 2021, the rate of growth in terms of prices for the United States amounted to +11.2% per year.
Base Year | Historical Period | Forecast Period | Units |
---|---|---|---|
2022 | 2012-2022 | 2023-2030 | US$, Tons |
Frequently Asked Questions (FAQ) :
This report provides an in-depth analysis of the medicaments containing insulin market in Hong Kong SAR, China. Within it, you will discover the latest data on market trends and opportunities by country, consumption, production and price developments, as well as the global trade (imports and exports). The forecast exhibits the market prospects through 2030.
Making Data-Driven Decisions to Grow Your Business
A Quick Overview of Market Performance
Understanding the Current State of The Market and Its Prospects
Finding New Products to Diversify Your Business
Choosing the Best Countries to Establish Your Sustainable Supply Chain
Choosing the Best Countries to Boost Your Exports
The Latest Trends and Insights into The Industry
The Largest Import Supplying Countries
The Largest Destinations for Exports
The Largest Producers on The Market and Their Profiles
Recommended reports
This report provides an in-depth analysis of the medicaments containing insulin market in Asia.
This report provides an in-depth analysis of the global medicaments containing insulin market.
This report provides an in-depth analysis of the medicaments containing insulin market in the EU.
This report provides an in-depth analysis of the medicaments containing insulin market in the U.S..
This report provides an in-depth analysis of the medicaments containing insulin market in China.
Join us in our latest webinar series to get insights from industry experts and engage in a productive discussion!
Tuesday, February 22nd, 2022 @ 04:00 pm ET
Join us in our latest webinar series to get insights from industry experts and engage in a productive discussion!
Tuesday, February 8th, 2022 @ 04:00 pm ET
Join us in our latest webinar series to get insights from industry experts and engage in a productive discussion!
Tuesday, January 25th, 2022 @ 04:00 pm ET